Home > EMCDDA manuals no 6. Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. A manual for provider-initiated voluntary medical examination, testing and counselling.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2010) EMCDDA manuals no 6. Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. A manual for provider-initiated voluntary medical examination, testing and counselling. Luxembourg: The Publications Office of the European Union. 75 p.

[img]
Preview
PDF (EMCDDA Manual 6) - Published Version
680kB

Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of risk behaviours, and because of underlying conditions such as poor hygiene, homelessness and poverty.

There is a recognised need for guidance on providing IDUs with a medical examination and testing for HIV, viral hepatitis and several other infections on a regular basis. In addition, improving testing uptake in this group would benefit epidemiological surveillance and monitoring as carried out at the national and international level.

These guidelines are accompanied by a recommended package of prevention and primary care in relation to injecting drug users and infections. Treatment and other specialist care are not discussed in detail but are dealt with by indicating referral to appropriate services.

Table of contents
• Summary
• Methodology and scope
• Part 1: Guidelines for voluntary medical examination, testing and counselling
• Chapter 1: Introduction
• Chapter 2: Providing medical examination, testing and counselling to IDUs
• Part 2: Background and implementation of the guidelines
• Chapter 3: Background
• Chapter 4: Implementation


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Alcohol or other drugs in general, Opioid
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:2010
Call No:REF. EMCDDA
Pages:75 p.
Publisher:The Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
ISBN:978-92-9168-414-4
EndNote:View
Accession Number:HRB 4901 (Available)
Related URLs:
Subjects:N Communication, information and education > Recommendations or guidelines > Practice / clinical guidelines
J Health care, prevention and rehabilitation > Drugs and alcohol prevention > Drugs and alcohol use harm reduction
J Health care, prevention and rehabilitation > Health-related prevention > Health information and education > Communicable disease control
HA Screening, identification, and diagnostic method > Medical screening and diagnostic method
T Demographic characteristics > Intravenous / injecting drug user
J Health care, prevention and rehabilitation > Health care administration > Health care quality control
J Health care, prevention and rehabilitation > Identification and screening
B Drugs and alcohol substances > Opioids (opiates)
G Health and disease > Disorder by cause > Communicable disease > Viral hepatitis
VA Geographic area > Europe
G Health and disease > Disorder by cause > Communicable disease > HIV infection

Repository Staff Only: item control page